Latest Commercialisation News

Carnegie Clean Energy’s Spanish subsidiary has received a significant pre-financing payment from the European Commission to advance innovations in wave energy technology through the COIN Project.

Race Oncology has raised $3.22 million through a private placement to fund its HARNESS-1 Phase 1a/b trial targeting non-small cell lung cancer, with patient enrolment expected early next year.

NH3 Clean Energy progresses its WAH2 Project through the FEED phase while forging a pivotal MoU with Japanese giant ITOCHU Corporation to develop clean ammonia bunkering in the Asia Pacific region by 2030.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.

State Gas Limited has raised $3.2 million through convertible notes issued at a 33% premium, alongside a $0.5 million director debt conversion, to accelerate pre-development of its Rolleston West coal seam gas project following a maiden 2P reserve certification.

Norwood Systems has successfully raised $650,000 through an oversubscribed share placement, aiming to fuel its market growth and strategic partnerships in AI-driven voice communication.

Bass Oil has signed a binding three-year gas sales agreement with Origin Energy for supply from the Vanessa Gas Project, marking a strategic entry into the East Coast Gas Market starting in 2026.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Sparc Hydrogen has appointed Alana Barlow as its inaugural CEO, marking a strategic move to accelerate commercialisation of its innovative photocatalytic water splitting technology for green hydrogen.

BPM Minerals has kicked off a significant 3,000m drilling campaign at its high-grade Beachcomber Prospect within the Forelands Gold Project, backed by a recent $3.5 million capital raise. Assay results expected early next year will be closely watched for signs of a major new gold resource in Western Australia.

Island Pharmaceuticals has been granted a pivotal US patent extending protection for its antiviral drug Galidesivir as a Covid-19 treatment until 2042, reinforcing its strategic position in the antiviral market.

Sparc Hydrogen has reached a pivotal milestone with sustained hydrogen generation at its Roseworthy pilot plant, advancing its innovative photocatalytic water splitting technology towards commercialisation.